mTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and aging

Publisher： John Wiley & Sons Inc

E-ISSN： 1749-6632|1346|1|33-44

ISSN： 0077-8923

Source： ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, Vol.1346, Iss.1, 2015-06, pp. : 33-44

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The mTOR Signalling Pathway in Human Cancer

By Pópulo Helena   Lopes José Manuel   Soares Paula  

International Journal of Molecular Sciences, Vol. 13, Iss. 2, 2012-02 ,pp. : 1886-1918

MDPI

Access to resources Recommend Favorite

mTOR Pathways in Cancer and Autophagy

By Paquette Mathieu   El-Houjeiri Leeanna   Pause Arnim  

Cancers, Vol. 10, Iss. 1, 2018-01 ,pp. : 18-18

MDPI

Access to resources Recommend Favorite

Activation of mTOR signaling pathway is secondary to neuronal excitability in a mouse model of mesio‐temporal lobe epilepsy

By  

EUROPEAN JOURNAL OF NEUROSCIENCE, Vol. 41, Iss. 7, 2015-04 ,pp. : 974-986

John Wiley & Sons Inc

Access to resources Recommend Favorite

Qiliqiangxin Protects Against Cardiac Ischemia-Reperfusion Injury via Activation of the mTOR Pathway

By  

Cellular Physiology and Biochemistry, Vol. 37, Iss. 2, 2015-08 ,pp. : 454-464

Karger

Access to resources Recommend Favorite

mTOR Pathway – Novel Modulator of Astrocyte Activity

By Latacz Anna   Russell John A.   Ocłoń Ewa   Zubel-Łojek Joanna   Pierzchała-Koziec Krystyna  

Folia Biologica, Vol. 63, Iss. 2, 2015-04 ,pp. : 95-105

Institute of Systematics and Evolution of Animals, Polish Academy of Sciences

Access to resources Recommend Favorite